In psychology, libido (//; from the Latin libīdō, 'desire') is psychological drive or energy, usually conceived as sexual in nature, but also includes other forms of desire. The term was originally used in psychoanalytic theory, where the neurologist and pioneering psychoanalyst Sigmund Freud began by employing the term in reference to the energy of the sexual drive, later generalising the concept to refer to the fundamental energy of all expressions of love, pleasure, and self-preservation.
In common or colloquial usage, a person's overall sexual drive is often referred to as that person's "libido". In this sense, libido is influenced by biological, psychological, and social factors. Biologically, the sex hormones and associated neurotransmitters that act upon the nucleus accumbens (primarily testosterone, estrogen, and dopamine, respectively) regulate sex drive in humans. Sexual drive can be affected by social factors such as work and family; psychological factors such as personality and stress; also by medical conditions, medications, lifestyle, relationship issues, and age.
|Part of a series of articles on|
Sigmund Freud, who is considered the originator of the modern use of the term, defined libido as "the energy, regarded as a quantitative magnitude... of those instincts which have to do with all that may be comprised under the word 'love'." It is the instinctual energy or force, contained in what Freud called the id, the strictly unconscious structure of the psyche. He also explained that it is analogous to hunger, the will to power, and so on insisting that it is a fundamental instinct that is innate in all humans.
Freud pointed out that these libidinal drives can conflict with the conventions of civilised behavior, represented in the psyche by the superego. It is this need to conform to society and control the libido that leads to tension and anxiety in the individual, prompting the use of ego defenses which channel the psychic energy of the unconscious drives into forms that are acceptable to the ego and superego. Excessive use of ego defenses results in neurosis, so a primary goal of psychoanalysis is to make the drives accessible to consciousness, allowing them to be addressed directly, thus reducing the patient's automatic resort to ego defenses.
Freud viewed libido as passing through a series of developmental stages in the individual, in which the libido fixates on different erogenous zones: first the oral stage (exemplified by an infant's pleasure in nursing), then the anal stage (exemplified by a toddler's pleasure in controlling his or her bowels), then the phallic stage, through a latency stage in which the libido is dormant, to its reemergence at puberty in the genital stage (Karl Abraham would later add subdivisions in both oral and anal stages.). Failure to adequately adapt to the demands of these different stages could result in libidinal energy becoming 'dammed up' or fixated in these stages, producing certain pathological character traits in adulthood.
Swiss psychiatrist Carl Gustav Jung identified the libido with psychic energy in general. According to Jung, 'energy', in its subjective and psychological sense, is 'desire', of which sexual desire is just one aspect. Libido thus denotes "a desire or impulse which is unchecked by any kind of authority, moral or otherwise. Libido is appetite in its natural state. From the genetic point of view it is bodily needs like hunger, thirst, sleep, and sex, and emotional states or affects, which constitute the essence of libido." It is "the energy that manifests itself in the life process and is perceived subjectively as striving and desire." Duality (opposition) creates the energy (or libido) of the psyche, which Jung asserts expresses itself only through symbols. These symbols may manifest as "fantasy-images" in the process of psychoanalysis, giving subjective expression to the contents of the libido, which otherwise lacks any definite form. Desire, conceived generally as a psychic longing, movement, displacement and structuring, manifests itself in definable forms which are apprehended through analysis.
A person may have a desire for sex, but not have the opportunity to act on that desire, or may on personal, moral or religious reasons refrain from acting on the urge. Psychologically, a person's urge can be repressed or sublimated. Conversely, a person can engage in sexual activity without an actual desire for it. Multiple factors affect human sex drive, including stress, illness, pregnancy, and others. A 2001 review found that, on average, men have a higher desire for sex than women.
Certain psychological or social factors can reduce the desire for sex. These factors can include lack of privacy or intimacy, stress or fatigue, distraction, or depression. Environmental stress, such as prolonged exposure to elevated sound levels or bright light, can also affect libido. Other causes include experience of sexual abuse, assault, trauma, or neglect, body image issues, and anxiety about engaging in sexual activity.
Individuals with post-traumatic stress disorder (PTSD) may find themselves with reduced sexual desire. Struggling to find pleasure, as well as having trust issues, many with PTSD experience feelings of vulnerability, rage and anger, and emotional shutdowns, which have been shown to inhibit sexual desire in those with PTSD. Reduced sex drive may also be present in trauma victims due to issues arising in sexual function. For women, it has been found that treatment can improve sexual function, thus helping restore sexual desire. Depression and libido decline often coincide, with reduced sex drive being one of the symptoms of depression. Those with depression often report the decline in libido to be far reaching and more noticeable than other symptoms. In addition, those with depression often are reluctant to report their reduced sex drive, often normalizing it with cultural/social values, or by the failure of the physician to inquire about it.
Sexual desires are often an important factor in the formation and maintenance of intimate relationships in humans. A lack or loss of sexual desire can adversely affect relationships. Changes in the sexual desires of any partner in a sexual relationship, if sustained and unresolved, may cause problems in the relationship. The infidelity of a partner may be an indication that a partner's changing sexual desires can no longer be satisfied within the current relationship. Problems can arise from disparity of sexual desires between partners, or poor communication between partners of sexual needs and preferences.
See also: Sexual motivation and hormones
Libido is governed primarily by activity in the mesolimbic dopamine pathway (ventral tegmental area and nucleus accumbens). Consequently, dopamine and related trace amines (primarily phenethylamine) that modulate dopamine neurotransmission play a critical role in regulating libido.
Other neurotransmitters, neuropeptides, and sex hormones that affect sex drive by modulating activity in or acting upon this pathway include:
A woman's desire for sex is correlated to her menstrual cycle, with many women experiencing a heightened sexual desire in the several days immediately before ovulation, which is her peak fertility period, which normally occurs two days before and until two days after the ovulation. This cycle has been associated with changes in a woman's testosterone levels during the menstrual cycle. According to Gabrielle Lichterman, testosterone levels have a direct impact on a woman's interest in sex. According to her, testosterone levels rise gradually from about the 24th day of a woman's menstrual cycle until ovulation on about the 14th day of the next cycle, and during this period the woman's desire for sex increases consistently. The 13th day is generally the day with the highest testosterone levels. In the week following ovulation, the testosterone level is the lowest and as a result women will experience less interest in sex.[better source needed]
Also, during the week following ovulation, progesterone levels increase, resulting in a woman experiencing difficulty achieving orgasm. Although the last days of the menstrual cycle are marked by a constant testosterone level, women's libido may get a boost as a result of the thickening of the uterine lining which stimulates nerve endings and makes a woman feel aroused. Also, during these days, estrogen levels decline, resulting in a decrease of natural lubrication.
Although some specialists disagree with this theory, menopause is still considered by the majority a factor that can cause decreased sexual desire in women. The levels of estrogen decrease at menopause and this usually causes a lower interest in sex and vaginal dryness which makes sex painful. However, the levels of testosterone increase at menopause and this may be why some women may experience a contrary effect of an increased libido.
Physical factors that can affect libido include endocrine issues such as hypothyroidism, the effect of certain prescription medications (for example flutamide), and the attractiveness and biological fitness of one's partner, among various other lifestyle factors.
Anemia is a cause of lack of libido in women due to the loss of iron during the period.
Smoking tobacco, alcohol use disorder, and the use of certain drugs can also lead to a decreased libido. Moreover, specialists suggest that several lifestyle changes such as exercising, quitting smoking, lowering consumption of alcohol or using prescription drugs may help increase one's sexual desire.
Some people purposefully attempt to decrease their libido through the usage of anaphrodisiacs. Aphrodisiacs, such as dopaminergic psychostimulants, are a class of drugs which can increase libido. On the other hand, a reduced libido is also often iatrogenic and can be caused by many medications, such as hormonal contraception, SSRIs and other antidepressants, antipsychotics, opioids, beta blockers and isotretinoin.
Isotretinoin, finasteride and many SSRIs uncommonly can cause a long-term decrease in libido and overall sexual function, sometimes lasting for months or years after users of these drugs have stopped taking them. These long-lasting effects have been classified as iatrogenic medical disorders, respectively termed post-retinoid sexual dysfunction/post-Accutane syndrome (PRSD/PAS), post-finasteride syndrome (PFS) and post-SSRI sexual dysfunction (PSSD). These three disorders share many overlapping symptoms in addition to reduced libido, and are thought to share a common etiology, but collectively remain poorly-understood and lack effective treatments.
Multiple studies have shown that with the exception of bupropion (Wellbutrin), trazodone (Desyrel) and nefazodone (Serzone), antidepressants generally will lead to lowered libido. SSRIs that typically lead to decreased libido are fluoxetine (Prozac), paroxetine (Paxil), fluvoxamine (Luvox), citalopram (Celexa) and sertraline (Zoloft). Some antidepressant users have tried decreasing their dosage in the hopes of maintaining an adequate sex drive.[examples needed] Other users try enrolling in psychotherapy to solve depression-related issues of libido. However, the effectiveness of this therapy is mixed, with many reporting that it had no or little effect on sexual drive.
Testosterone is one of the hormones controlling libido in human beings. Emerging research is showing that hormonal contraception methods like oral contraceptive pills (which rely on estrogen and progesterone together) are causing low libido in females by elevating levels of sex hormone-binding globulin (SHBG). SHBG binds to sex hormones, including testosterone, rendering them unavailable. Research is showing that even after ending a hormonal contraceptive method, SHBG levels remain elevated and no reliable data exists to predict when this phenomenon will diminish.
Oral contraceptives lower androgen levels in users, and lowered androgen levels generally lead to a decrease in sexual desire. However, usage of oral contraceptives has shown to typically not have a connection with lowered libido in women.
Males reach the peak of their sex drive in their teenage years[dubious ], while females reach it in their thirties. The surge in testosterone hits the male at puberty resulting in a sudden and extreme sex drive which reaches its peak at age 15–16, then drops slowly over his lifetime.[disputed ] In contrast, a female's libido increases slowly during adolescence and peaks in her mid-thirties.[why?] Actual testosterone and estrogen levels that affect a person's sex drive vary considerably.
Some boys and girls will start expressing romantic or sexual interest by age 10–12. The romantic feelings are not necessarily sexual, but are more associated with attraction and desire for another. For boys and girls in their preteen years (ages 11–12), at least 25% report "thinking a lot about sex". By the early teenage years (ages 13–14), however, boys are much more likely to have sexual fantasies than girls. In addition, boys are much more likely to report an interest in sexual intercourse at this age than girls. Masturbation among youth is common, with prevalence among the population generally increasing until the late 20s and early 30s. Boys generally start masturbating earlier, with less than 10% boys masturbating around age 10, around half participating by age 11–12, and over a substantial majority by age 13–14. This is in sharp contrast to girls where virtually none are engaging in masturbation before age 13, and only around 20% by age 13–14.
People in their 60s and early 70s generally retain a healthy sex drive, but this may start to decline in the early to mid-70s. Older adults generally develop a reduced libido due to declining health and environmental or social factors. In contrast to common belief, postmenopausal women often report an increase in sexual desire and an increased willingness to satisfy their partner. Women often report family responsibilities, health, relationship problems, and well-being as inhibitors to their sexual desires. Aging adults often have more positive attitudes towards sex in older age due to being more relaxed about it, freedom from other responsibilities, and increased self-confidence. Those exhibiting negative attitudes generally cite health as one of the main reasons. Stereotypes about aging adults and sexuality often regard seniors as asexual beings, doing them no favors when they try to talk about sexual interest with caregivers and medical professionals. Non-western cultures often follow a narrative of older women having a much lower libido, thus not encouraging any sort of sexual behavior for women. Residence in retirement homes has affects on residents' libidos. In these homes, sex occurs, but it is not encouraged by the staff or other residents. Lack of privacy and resident gender imbalance are the main factors lowering desire. Generally, for older adults, being excited about sex, good health, sexual self-esteem and having a sexually talented partner can be factors.
Sexual desire disorders are more common in women than in men, and women tend to exhibit less frequent and less intense sexual desires than men. Erectile dysfunction may happen to the penis because of lack of sexual desire, but these two should not be confused since the two can commonly occur simultaneously. For example, moderate to large recreational doses of cocaine, amphetamine or methamphetamine can simultaneously cause erectile dysfunction (evidently due to vasoconstriction) while still significantly increasing libido due to heightened levels of dopamine. Although conversely, excessive or very regular/repeated high-dose amphetamine use may damage leydig cells in the male testes, potentially leading to markedly lowered sexual desire subsequently due to hypogonadism. However in contrast to this, other stimulants such as cocaine and even caffeine appear to lack negative impacts on testosterone levels, and may even increase their concentrations in the body. Studies on cannabis however seem to be exceptionally mixed, with some claiming decreased levels on testosterone, others reporting increased levels, and with some showing no measurable changes at all. This varying data seems to coincidence with the almost equally conflicting data on cannabis' effects on sex drive as well, which may be dosage or frequency-dependent, due to different amounts of distinct cannabinoids in the plant, or based on individual enzyme properties responsible for metabolism of the drug. Evidence on alcohol's effects on testosterone however invariably show a clear decrease, however (like amphetamine, albeit to a lesser degree); temporary increases in libido and related sexual behavior have long been observed during alcohol intoxication in both sexes, but likely most noticeable with moderation, particularly in males. Additionally, men often also naturally experience a decrease in their libido as they age due to decreased productions in testosterone.
The American Medical Association has estimated that several million US women have a female sexual arousal disorder, though arousal is not at all synonymous with desire, so this finding is of limited relevance to the discussion of libido. Some specialists claim that women may experience low libido due to some hormonal abnormalities such as lack of luteinising hormone or androgenic hormones, although these theories are still controversial.
All the evidence we have reviewed points toward the conclusion that men desire sex more than women. Although some of the findings were more methodologically rigorous than others, the unanimous convergence across all measures and findings increases confidence. We did not find a single study, on any of nearly a dozen different measures, that found women had a stronger sex drive than men. We think that the combined quantity, quality, diversity, and convergence of the evidence render the conclusion indisputable
((cite news)): CS1 maint: multiple names: authors list (link)
Recent evidence suggests that popular party drugs such as MDMA and gamma-hydroxybutyrate (GHB) may preferentially activate brain oxytocin systems to produce their characteristic prosocial and prosexual effects. Oxytocin interacts with the mesolimbic dopamine system to facilitate sexual and social behaviour, and this oxytocin-dopamine interaction may also influence the acquisition and expression of drug-seeking behaviour.